EMEA-000013-PIP01-07-M03
Key facts
| Active substance |
recombinant L-asparaginase
|
| Therapeutic area |
Oncology
|
| Decision number |
P/0084/2013
|
| PIP number |
EMEA-000013-PIP01-07-M03
|
| Pharmaceutical form(s) |
Powder for solution for injection or infusion
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
|
| Contact for public enquiries |
Medac Gesellschaft für klinische Spezialpräparate mbH
E-mail: j.kuehnel@medac.de |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-000013-PIP01-07-M03
|
| Compliance opinion date |
14/06/2013
|
| Compliance outcome |
positive
|